These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17723306)

  • 1. Synthesis and antidiabetic activity of 2,5-disubstituted-3-imidazol-2-yl-pyrrolo[2,3-b]pyridines and thieno[2,3-b]pyridines.
    Bahekar RH; Jain MR; Jadav PA; Prajapati VM; Patel DN; Gupta AA; Sharma A; Tom R; Bandyopadhya D; Modi H; Patel PR
    Bioorg Med Chem; 2007 Nov; 15(21):6782-95. PubMed ID: 17723306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines.
    Bahekar RH; Jain MR; Goel A; Patel DN; Prajapati VM; Gupta AA; Jadav PA; Patel PR
    Bioorg Med Chem; 2007 May; 15(9):3248-65. PubMed ID: 17339113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antidiabetic activity of 3,6,7-trisubstituted-2-(1H-imidazol-2-ylsulfanyl)quinoxalines and quinoxalin-2-yl isothioureas.
    Bahekar RH; Jain MR; Gupta AA; Goel A; Jadav PA; Patel DN; Prajapati VM; Patel PR
    Arch Pharm (Weinheim); 2007 Jul; 340(7):359-66. PubMed ID: 17567824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
    Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
    J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridine-2-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS; Almaden JV; Barnum SJ; Carlson TJ; Do QQ; Fraser JD; Hess M; Kim YH; Ogilvie KM; Sun S
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6116-9. PubMed ID: 16979341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a series of imidazo[4,5-b]pyridines with dual activity at angiotensin II type 1 receptor and peroxisome proliferator-activated receptor-γ.
    Casimiro-Garcia A; Filzen GF; Flynn D; Bigge CF; Chen J; Davis JA; Dudley DA; Edmunds JJ; Esmaeil N; Geyer A; Heemstra RJ; Jalaie M; Ohren JF; Ostroski R; Ellis T; Schaum RP; Stoner C
    J Med Chem; 2011 Jun; 54(12):4219-33. PubMed ID: 21557540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyridine-3-propanoic acids: Discovery of dual PPARalpha/gamma agonists as antidiabetic agents.
    Humphries PS; Bailey S; Almaden JV; Barnum SJ; Carlson TJ; Christie LC; Do QQ; Fraser JD; Hess M; Kellum J; Kim YH; McClellan GA; Ogilvie KM; Simmons BH; Skalitzky D; Sun S; Wilhite D; Zehnder LR
    Bioorg Med Chem Lett; 2006 Dec; 16(23):6120-3. PubMed ID: 16973358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F9 (4-(3,6-bis (ethoxycarbonyl)-4,5,6,7-tetrahydrothieno (2,3-c) pyridin-2-ylamino)-4-oxobutanoic acid) enhances insulin-mediated glucose uptake in vitro and exhibits antidiabetic activity in vivo in db/db mice.
    Anandharajan R; Sayyed SG; Doshi LS; Dixit P; Chandak PG; Dixit AV; Brahma MK; Deshmukh NJ; Gupte R; Damre A; Suthar J; Padigaru M; Sharma SD; Nemmani KV
    Metabolism; 2009 Oct; 58(10):1503-16. PubMed ID: 19608207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and structure-activity relationships study of thieno[2,3-b]pyridine analogues as hepatic gluconeogenesis inhibitors.
    Ma F; Liu J; Zhou T; Lei M; Chen J; Wang X; Zhang Y; Shen X; Hu L
    Eur J Med Chem; 2018 May; 152():307-317. PubMed ID: 29733999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential antidiabetic agents. Pyrazolo(3,4-b)pyridines.
    Höhn H; Polacek I; Schulze E
    J Med Chem; 1973 Dec; 16(12):1340-6. PubMed ID: 4358224
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and antidiabetic activity of morpholinothiazolyl-2,4-thiazolidindione derivatives.
    Ezer M; Yıldırım LT; Bayro O; Verspohl EJ; Dundar OB
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):419-27. PubMed ID: 21740103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice.
    Yoshida S; Ohishi T; Matsui T; Tanaka H; Oshima H; Yonetoku Y; Shibasaki M
    Biochem Biophys Res Commun; 2010 Nov; 402(2):280-5. PubMed ID: 20937249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antidiabetic activity of 2,4-thiazolidindione, imidazolidinedione and 2-thioxo-imidazolidine-4-one derivatives bearing 6-methyl chromonyl pharmacophore.
    Unlusoy MC; Kazak C; Bayro O; Verspohl EJ; Ertan R; Dundar OB
    J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1205-10. PubMed ID: 23057864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel euglycemic and hypolipidemic agents. 4. Pyridyl- and quinolinyl-containing thiazolidinediones.
    Lohray BB; Bhushan V; Reddy AS; Rao PB; Reddy NJ; Harikishore P; Haritha N; Vikramadityan RK; Chakrabarti R; Rajagopalan R; Katneni K
    J Med Chem; 1999 Jul; 42(14):2569-81. PubMed ID: 10411477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antidiabetic activity of some new chromonyl-2,4-thiazolidinediones.
    Ceylan-Ünlüsoy M; Verspohl EJ; Ertan R
    J Enzyme Inhib Med Chem; 2010 Dec; 25(6):784-9. PubMed ID: 20687791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro.
    Liu YX; Si MM; Lu W; Zhang LX; Zhou CX; Deng SL; Wu HS
    J Ethnopharmacol; 2015 May; 166():168-75. PubMed ID: 25792018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.
    Patnaik S; Stevens KL; Gerding R; Deanda F; Shotwell JB; Tang J; Hamajima T; Nakamura H; Leesnitzer MA; Hassell AM; Shewchuck LM; Kumar R; Lei H; Chamberlain SD
    Bioorg Med Chem Lett; 2009 Jun; 19(11):3136-40. PubMed ID: 19394223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives.
    Rathish IG; Javed K; Bano S; Ahmad S; Alam MS; Pillai KK
    Eur J Med Chem; 2009 Jun; 44(6):2673-8. PubMed ID: 19171410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison on hypoglycemic and antioxidant activities of the fresh and dried Portulaca oleracea L. in insulin-resistant HepG2 cells and streptozotocin-induced C57BL/6J diabetic mice.
    Gu JF; Zheng ZY; Yuan JR; Zhao BJ; Wang CF; Zhang L; Xu QY; Yin GW; Feng L; Jia XB
    J Ethnopharmacol; 2015 Feb; 161():214-23. PubMed ID: 25523372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-[4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones.
    Sohda T; Momose Y; Meguro K; Kawamatsu Y; Sugiyama Y; Ikeda H
    Arzneimittelforschung; 1990 Jan; 40(1):37-42. PubMed ID: 2339998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.